Works by Yerushalmi, Ronit


Results: 32
    1
    2

    Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1011, doi. 10.1002/ajh.24827
    By:
    • Shimoni, Avichai;
    • Vago, Luca;
    • Bernardi, Massimo;
    • Yerushalmi, Ronit;
    • Peccatori, Jacopo;
    • Greco, Raffaella;
    • Shem-Tov, Noga;
    • Lo Russo, Alessandro;
    • Danylesko, Ivetta;
    • Apel, Arie;
    • Bonini, Chiara;
    • Lupo Stanghellini, Maria Teresa;
    • Nagler, Arnon;
    • Ciceri, Fabio
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis.

    Published in:
    Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00547
    By:
    • Ni, Ming;
    • Wang, Lei;
    • Yang, Mingya;
    • Neuber, Brigitte;
    • Sellner, Leopold;
    • Hückelhoven-Krauss, Angela;
    • Schubert, Maria-Luisa;
    • Luft, Thomas;
    • Hegenbart, Ute;
    • Schönland, Stefan;
    • Wuchter, Patrick;
    • Chen, Bao-an;
    • Eckstein, Volker;
    • Krüger, William;
    • Yerushalmi, Ronit;
    • Beider, Katia;
    • Nagler, Arnon;
    • Müller-Tidow, Carsten;
    • Dreger, Peter;
    • Schmitt, Michael
    Publication type:
    Article
    16

    Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02207
    By:
    • Wang, Lei;
    • Ni, Ming;
    • Hückelhoven-Krauss, Angela;
    • Sellner, Leopold;
    • Hoffmann, Jean-Marc;
    • Neuber, Brigitte;
    • Luft, Thomas;
    • Hegenbart, Ute;
    • Schönland, Stefan;
    • Kleist, Christian;
    • Sill, Martin;
    • Chen, Bao-an;
    • Wuchter, Patrick;
    • Eckstein, Volker;
    • Krüger, William;
    • Hilgendorf, Inken;
    • Yerushalmi, Ronit;
    • Nagler, Arnon;
    • Müller-Tidow, Carsten;
    • Ho, Anthony D.
    Publication type:
    Article
    17
    18
    19

    Venetoclax is safe and efficacious in relapsed/refractory AML.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 9, p. 2221, doi. 10.1080/10428194.2020.1761964
    By:
    • Ganzel, Chezi;
    • Ram, Ron;
    • Gural, Alexander;
    • Wolach, Ofir;
    • Gino-Moor, Sharon;
    • Vainstein, Vladimir;
    • Nachmias, Boaz;
    • Apel, Arie;
    • Koren-Michowitz, Maya;
    • Pasvolsky, Oren;
    • Yerushalmi, Ronit;
    • Danylesko, Ivetta;
    • Cohen, Yosef;
    • Peretz, Galit;
    • Moshe, Yakir;
    • Zektser, Miri;
    • Yeganeh, Shay;
    • Rowe, Jacob M.;
    • Ofran, Yishai
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32